Adelaide researchers are putting the call out to Australian adults living with multiple myeloma or smouldering myeloma to take part in a new national program designed to give people facing this ... Seeking Alpha: J&J says Darzalex injectable granted EU nod for smouldering multiple myeloma The American Journal of Managed Care: The Questions Are Just Beginning as Smoldering Myeloma Enters a New Era: Peter Voorhees, MD The Questions Are Just Beginning as Smoldering Myeloma Enters a New Era: Peter Voorhees, MD Please provide your email address to receive an email when new articles are posted on . Daratumumab delayed progression of smoldering multiple myeloma compared with active monitoring.
Among those who ... The FDA on Thursday approved daratumumab-hyaluronidase (Darzalex Faspro) as the first drug for high-risk smoldering multiple myeloma. Approval of the subcutaneous daratumumab product was based on ... MedPage Today: Daratumumab Passes Key Hurdle to First Approved Treatment for Smoldering Myeloma A potential first-ever FDA-approved treatment for smoldering myeloma received a positive review from an advisory committee, but not without reservations, even from panelists who voted in favor.
